Itron, Inc. (NASDAQ:ITRI) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Itron, Inc. has received a consensus rating of "Moderate Buy" from twelve analysts, with an average target price of $136.25 per share.
• The company recently reported earnings of $1.62 per share, exceeding analyst expectations, although revenue slightly declined year-over-year.
• Insider trading activity includes CFO Joan S. Hooper and SVP Christopher E. Ware selling shares, reflecting a 1.09% and 1.80% decrease in their ownership, respectively.

Shares of Itron, Inc. (NASDAQ:ITRI - Get Free Report) have earned an average rating of "Moderate Buy" from the twelve analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $136.25.

Several equities analysts have recently commented on ITRI shares. Stephens set a $130.00 price objective on shares of Itron in a report on Monday, August 4th. Roth Capital upped their price objective on shares of Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd. Piper Sandler decreased their price objective on shares of Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. JPMorgan Chase & Co. upgraded shares of Itron from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Finally, TD Cowen upped their target price on shares of Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a research note on Friday, June 20th.

Itron Stock Performance

ITRI opened at $122.94 on Tuesday. The firm has a market capitalization of $5.62 billion, a PE ratio of 21.02, a PEG ratio of 0.67 and a beta of 1.46. Itron has a twelve month low of $90.11 and a twelve month high of $140.04. The firm's 50-day moving average price is $130.20 and its 200 day moving average price is $116.24. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48.

Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. Itron's quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the business posted $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, sell-side analysts expect that Itron will post 5.33 EPS for the current fiscal year.

Insider Activity

In related news, CFO Joan S. Hooper sold 970 shares of the company's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the sale, the chief financial officer directly owned 88,394 shares of the company's stock, valued at $11,076,652.14. This represents a 1.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Christopher E. Ware sold 351 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $43,983.81. Following the completion of the sale, the senior vice president directly owned 19,117 shares in the company, valued at approximately $2,395,551.27. This represents a 1.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,073 shares of company stock worth $1,480,880 over the last 90 days. Company insiders own 1.51% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. State of Wyoming purchased a new position in shares of Itron in the 2nd quarter valued at $214,000. Castleark Management LLC boosted its stake in Itron by 29.2% during the 2nd quarter. Castleark Management LLC now owns 62,330 shares of the scientific and technical instruments company's stock worth $8,204,000 after purchasing an additional 14,100 shares during the period. Public Sector Pension Investment Board boosted its stake in Itron by 8.6% during the 2nd quarter. Public Sector Pension Investment Board now owns 155,372 shares of the scientific and technical instruments company's stock worth $20,452,000 after purchasing an additional 12,354 shares during the period. FORA Capital LLC acquired a new stake in Itron during the 2nd quarter worth $665,000. Finally, Tower Research Capital LLC TRC boosted its stake in Itron by 434.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,798 shares of the scientific and technical instruments company's stock worth $763,000 after purchasing an additional 4,714 shares during the period. 96.19% of the stock is owned by hedge funds and other institutional investors.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.